u/Avish_Golakiya · 3h ago7 prior · awaiting results
“Listed for completeness, not picked”
10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.
Ameluz PDT expansion to superficial basal cell shows 65.5% efficacy vs 4.8% control in pivotal trial, with real PDUFA on Sep 28. High probability on data alone, but the $21M market cap and $5M liquidity make comfortable sizing difficult.
Now $1.6115m ago